Ann: Litigation Update, page-74

got you covered here @panther22

woe #1 - money. substantially all IP hocked to Oaktree with no more money available and a number of covenants restricting operations. I'd say execs and board taking pay cuts in the short term is an indication of money related woe (or an admission they have been being paid too much in the first place)

woe #2 - approvals. or lack thereof. more than two years of back and forth with the FDA when had they provided what was required in the first place.

woe #3 - constant and continual inability to hold onto partnerships. plural. now it could very well be that there were myriad reasons for all these failed partnerships but there is one common denominator there....

shall we continue? (and they were never heard from again?)